ALLOX is a spin-off of the Centre for Genomic Regulation (CRG) and draws on the expertise and technology developed in the lab of Ben Lehner. The company was born out of the realisation that combining systematic mutagenesis, high-throughput phenotyping and biophysical modelling has the potential to revolutionise drug development but also transform biotechnology in general. We are currently incubating in the beautiful beachfront setting of the Barcelona Biomedical Research Park (PRBB), and our immediate goal is to identify allosteric switches in all proteins and then leverage this unprecedented resource to rapidly develop novel medicines to treat human diseases. Our long-term vision is to become a leader in programmable biology, building the next generation of tools to predict, design and engineer new protein functions.
Company Details
- Employees
- 22
- Founded
- -
- Address
- Carrer De Baldiri Reixac, 4, Barcelona,catalonia 08028,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.allox.bio/
- HQ
- Barcelona, Catalonia
Allox Questions
Allox's website is https://www.allox.bio/
Allox's LinkedIn profile is https://es.linkedin.com/company/allox-bio
Allox has
22 employees.
View email and phone details for 22
employees at Allox.
Allox's industry is
Biotechnology Research
Allox's top competitors are
Orikine Bio,
Ochre Bio,
Ona Therapeutics,
Asabys Partners,
Augustine Therapeutics,
Turing Biosystems,
Splicebio,
Gradient Denervation Technologies,
Deepull,
Nuage Therapeutics.
Allox's categories are Biotechnology Research
Allox's founding year is 2023
